Table 1.
The combination therapy of surgery and chemotherapy for rPENT
| Patient | Age (years) | Gender | Diagnosis | Metastases | Treatment | Chemotherapeutic agents | Follow-up | Outcome |
|---|---|---|---|---|---|---|---|---|
| 14 |
16 |
F |
Right rPENT |
No |
Nephrectomy + chemotherapy |
Ifosfamide Vincristine Vinblastine Dactinomycin Adriamycin |
>4 years |
Alive with complete remission |
| 25 |
26 |
F |
Right rPENT |
Lung metastasesat 2 monthsafter nephrectomy |
Nephrectomy + chemotherapy, After metastases: sorafenib |
Vincristine Adriamycin Cyclophosphamide Ifosfamide Etoposide |
17 months |
Alive with stabilized lung metastases |
| 36 |
21 |
M |
Rihgt rPENT |
Liver metastasesat 6 monthsafter nephrectomy |
Nephrectomy,After metastases: Chemotherapy + partial hepatectomy |
Doxorubicin Ifosfamide Etoposide |
21 months |
Alive |
| 47 | 9 | M | Right rPENT | No | Nephrectomy + chemotherapy | Vincristine Doxorubicin Cyclophosphamide Ifosfamide Etoposide | 10 months | Relapse in the paraspinal cervical region |